Cargando…

Extracellular vesicles released by ovarian carcinoma contain arginase 1 that mitigates antitumor immune response

Expression of arginase-1 (ARG1) is an immunosuppressive feature of tumor microenvironment that leads to depletion of ʟ-arginine, a nutrient required for T-cells expansion. Ovarian carcinoma cells release extracellular vesicles carrying enzymatically active ARG1, that contributes to local and systemi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sosnowska, Anna, Czystowska-Kuzmicz, Malgorzata, Golab, Jakub
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2019
Materias:	Author's View
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791438/ https://www.ncbi.nlm.nih.gov/pubmed/31646104 http://dx.doi.org/10.1080/2162402X.2019.1655370

Ejemplares similares

Small extracellular vesicles containing arginase-1 suppress T-cell responses and promote tumor growth in ovarian carcinoma
por: Czystowska-Kuzmicz, Malgorzata, et al.
Publicado: (2019)

Epigenetic remodeling combined with photodynamic therapy elicits anticancer immune responses
por: Wachowska, Malgorzata, et al.
Publicado: (2014)

Extracellular Vesicles—A New Potential Player in the Immunology of Renal Cell Carcinoma
por: Kleibert, Marcin, et al.
Publicado: (2022)

Immunosuppressive Extracellular Vesicles as a Linking Factor in the Development of Tumor and Endometriotic Lesions in the Gynecologic Tract
por: Soroczynska, Karolina, et al.
Publicado: (2022)

Arginase Inhibition Mitigates Bortezomib-Exacerbated Cardiotoxicity in Multiple Myeloma
por: Paterek, Aleksandra, et al.
Publicado: (2023)

“Liquid biopsy” - extracellular vesicles as potential novel players towards precision medicine in asthma
por: Ambrożej, Dominika, et al.
Publicado: (2022)

Extracellular vesicles as potential tools for regenerative therapy
por: Rodriguez-Navarro, Jose Antonio, et al.
Publicado: (2020)

Push and release: TLR9 activation plus STAT3 blockade for systemic antitumor immunity
por: Kortylewski, Marcin, et al.
Publicado: (2014)

Small extracellular vesicles: multi-faceted tools for leukemia immune evasion in vivo
por: Gargiulo, Ernesto, et al.
Publicado: (2022)

Polyamine blockade promotes antitumor immunity
por: Hayes, Candace S, et al.
Publicado: (2014)

Retinoic acid on stage in antitumor immunity
por: Guo, Yanxia, et al.
Publicado: (2013)

Targeting coagulation to unlock antitumor immunity?
por: Galmiche, Antoine, et al.
Publicado: (2022)

Catechins and antitumor immunity: Not MDSC’s cup of tea
por: Santilli, Giorgia, et al.
Publicado: (2013)

Crucial role of inflammatory monocytes in antitumor immunity
por: Pommier, Arnaud, et al.
Publicado: (2013)

Engineering effective T-cell based antitumor immunity
por: Gruber, Thomas, et al.
Publicado: (2013)

Targeting arginase-1 exerts antitumor effects in multiple myeloma and mitigates bortezomib-induced cardiotoxicity
por: Ramji, Kavita, et al.
Publicado: (2022)

Myeloid Cell-Derived Arginase in Cancer Immune Response
por: Grzywa, Tomasz M., et al.
Publicado: (2020)

Potentiating antitumor immunity with αGC-loaded exosomes
por: Gehrmann, Ulf, et al.
Publicado: (2013)

High endothelial venules: Help or hindrance in the quest for antitumor immunity?
por: Gallimore, Awen, et al.
Publicado: (2013)

Activation of systemic antitumor immunity via TRAIL-induced apoptosis
por: James, Britnie R., et al.
Publicado: (2012)

A Janus-faced role of the unfolded protein response in antitumor immunity
por: Mahadevan, Navin R., et al.
Publicado: (2013)

Monocyte-derived dendritic cells: Emerging players in the antitumor immune response
por: Kuhn, Sabine, et al.
Publicado: (2013)

B7-H4 is a positive regulator of antitumor immunity
por: Rahbar, Ramtin, et al.
Publicado: (2015)

A clinically useful approach to enhance immunological memory and antitumor immunity
por: Berezhnoy, Alex, et al.
Publicado: (2014)

RON promotes the metastatic spread of breast carcinomas by subverting antitumor immune responses
por: Eyob, Henok, et al.
Publicado: (2013)

Characterization of Extracellular Vesicles from Bronchoalveolar Lavage Fluid and Plasma of Patients with Lung Lesions Using Fluorescence Nanoparticle Tracking Analysis
por: Dlugolecka, Magdalena, et al.
Publicado: (2021)

Targeting human CD27 with an agonist antibody stimulates T-cell activation and antitumor immunity
por: Thomas, Lawrence J, et al.
Publicado: (2014)

Tertiary lymphoid structures in human lung cancers, a new driver of antitumor immune responses
por: Goc, Jérémy, et al.
Publicado: (2014)

Is preexisting antitumor CD4 T cell response indispensable for the chemotherapy induced immune regression of cancer?
por: Godet, Yann, et al.
Publicado: (2012)

Two is better than one: Complementing oncolytic virotherapy with gemcitabine to potentiate antitumor immune responses
por: Gujar, Shashi A, et al.
Publicado: (2014)

Enhancing the antitumor effects of radiotherapy with combinations of immunostimulatory antibodies
por: Verbrugge, Inge, et al.
Publicado: (2012)

The short and sweet of T-cell therapy: Restraining glycolysis enhances the formation of immunological memory and antitumor immune responses
por: Sukumar, Madhusudhanan, et al.
Publicado: (2014)

Antibody-based depletion of Foxp3+ T cells potentiates antitumor immune memory stimulated by mTOR inhibition
por: Kim, Hyung L
Publicado: (2014)

PD-L1 expression and tumor-infiltrating lymphocytes: Revisiting the antitumor immune response potential in breast cancer
por: Schalper, Kurt A
Publicado: (2014)

Licensing of γδT cells for professional antigen presentation: A new role for antibodies in regulation of antitumor immune responses
por: Anderson, John, et al.
Publicado: (2012)

New role for antigen-presenting activated pDCs in promoting Th17 cells and impacting antitumor immunity
por: Guéry, Leslie, et al.
Publicado: (2015)

Synergistic antitumor effects of a TGFβ inhibitor and cyclophosphamide
por: Chen, Xin, et al.
Publicado: (2014)

Arming NK cells with enhanced antitumor activity: CARs and beyond
por: Oberoi, Pranav, et al.
Publicado: (2013)

Role of the complement system in NK cell-mediated antitumor T-cell responses
por: Janelle, Valérie, et al.
Publicado: (2014)

A novel actor in antitumoral immunity: The thymus-specific serine protease TSSP/PRSS16 involved in CD4(+) T-cell maturation
por: Brisson, Lydie, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_rjp576lu421og76finl8lj0veo